Skip to main content
Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.247
-0.004 (-1.51%)
At close: Nov 20, 2024, 4:00 PM
0.260
+0.013 (5.14%)
Pre-market: Nov 21, 2024, 7:08 AM EST

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $1.58M in the quarter ending September 30, 2024, a decrease of -5.87%. This brings the company's revenue in the last twelve months to $4.02M, down -42.41% year-over-year. In the year 2023, Petros Pharmaceuticals had annual revenue of $5.82M, down -2.83%.

Revenue (ttm)
$4.02M
Revenue Growth
-42.41%
P/S Ratio
0.37
Revenue / Employee
$191,542
Employees
21
Market Cap
2.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 201915.58M1.53M10.86%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 25.47M
Regional Health Properties 15.94M
Nuwellis 8.97M
ReShape Lifesciences 8.18M
Avinger 7.26M
Sintx Technologies 3.25M
Revenue Rankings

PTPI News

More News